Clinical Trial Update: Combination Immunotherapy Targeting Sarcomas [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update for a combination immunotherapy targeting sarcomas across Phase 1 and Phase 2 stages, with conditions including sarcoma, osteoid osteosa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ewing Sarcoma
• Osteoid Osteosarcoma
• Sarcoma

Snippet

Sponsor: Shenzhen Geno-Immune Medical Institute | Conditions: Sarcoma, Osteoid Sarcoma | Phase 1, Phase 2 | Status: UNKNOWN